Allergan pulled up by FDA

Article

The FDA has sent Allergan a warning letter relating to misleading information printed in a professional journal advertisement for its ophthalmic solution, Acular LS.

The FDA has sent Allergan a warning letter relating to misleading information printed in a professional journal advertisement for its ophthalmic solution, Acular LS.

The FDA remonstrated Allergan for printing information that broadens the product's indication, presents unsubstantiated superiority claims and omits important risk information for Acular LS.

Acular LS, according to the FDA approved product labelling, is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

Related Videos
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Esen K. Akpek, MD, Professor at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, converses via zoom with David Hutton of Ophthalmology Times
Dr Ali Erginay discusses his EURETINA presentation
Related Content
A crowd listens to a speaker at a conference. Image credit: ©Bojan – stock.adobe.com

AAO 2023 brings data, diagnostics and digital workflows to the forefront

December 8th 2023
Article

Experts from around the globe converged in San Francisco, California

A nurse helps a patient who uses a walker and glasses. Image credit: ©Dorde – stock.adobe.com

Collaborative rheumatologic–ophthalmologic teams could improve management of patients with rheumatic diseases

December 7th 2023
Article

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

A physician uses a stylus to look at the image of a cornea. Image credit: ©warloka79 – stock.adobe.com

Why the future of ophthalmology is in corneal grafts

December 6th 2023
Article

Restoration and regeneration represent a new paradigm

A patient covers her eye to perform a Snellen chart test as the optometrist looks on. Image credit: ©megaflopp – stock.adobe.com

New research data reflect patient satisfaction following faricimab treat-and-extend regimen

December 5th 2023
Article

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

An optometrist examines an elderly patient's eyes. Image credit: ©Nadia L/peopleimages.com – stock.adobe.com

Prevent Blindness participates in first-ever World Geographic Atrophy Day

December 5th 2023
Article

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals

An eyeball with a view of the globe imposed on the iris. Image credit: ©Chris Tefme – stock.adobe.com

A global view of diabetic eye disease

December 4th 2023
Article

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

© 2023 MJH Life Sciences

All rights reserved.